William Blair analyst Brandon Vazquez has maintained their bullish stance on CBLL stock, giving a Buy rating on October 20.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Brandon Vazquez has given his Buy rating due to a combination of factors that highlight Ceribell, Inc.’s strong performance and future potential. The company reported third-quarter sales that exceeded expectations by 4%, driven by better-than-anticipated account openings and utilization rates. This positive performance, despite challenging comparisons, suggests a robust growth trajectory, which is further supported by the company’s upward revision of its full-year guidance.
Looking ahead, Vazquez sees potential for further acceleration in Ceribell’s business. This optimism is based on the anticipated growth of the company’s team, which is expected to mature by 2026, and the expansion into the neonate market, with a new product launch planned for the same year. With shares trading at a favorable multiple of future sales and expected sales growth of over 30%, Vazquez maintains an Outperform rating, anticipating that commercial investments will enhance the company’s fundamentals and drive share value upward.
In another report released on October 20, Raymond James also initiated coverage with a Buy rating on the stock with a $19.00 price target.